InvestorsHub Logo
Followers 8
Posts 1500
Boards Moderated 0
Alias Born 07/22/2013

Re: Batermere post# 79673

Thursday, 09/06/2018 2:11:10 AM

Thursday, September 06, 2018 2:11:10 AM

Post# of 108191
Exactly! It’s about helping bring a new Therapy where it’s needed. I’m sure we did them a solid and then in return we could be seeing validation of our Lm platform. Which at this time is worth more than cash even though we need cash badly. We need positive proof that all our constructs are worthy of cash deals with upfront money! I’m telling you all this is a good thing and Ken B. seems to know the right people looking for deals concerning new cancer Immunotherapy treatments for the future. Our technology isn’t out dated it’s just being buried by mismanagement and greedy Shorts pouncing on every piece of promising news for the last 10 years.
Going forward will be very tricky unless Ken B. Can convince NEW Institutions to invest and show them the new direction in which he plans on taking us! Big difference between us and his old company we actually have the goods where at his old job that wasn’t the case! So much greed and stupidity from old management that absolutely put the cart before the horse, he now has to string together a couple of shoe strings to get this turned around! I still believe dilution is eminent but he’s trying to do everything in his power to get enough cash to wait till we go higher! I like this CEO much more than any of our last ones.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News